|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.37 CNY | -2.69% |
|
-4.14% | +0.27% |
| 06-09 | Jumpcan Pharma Gets Registration Certificate for Marboxil Tablets | MT |
| 05-18 | Jumpcan Pharma Gains Protection Status for Traditional Chinese Medicine | MT |
| Market Cap | 24.99B 3.69B 3.2B 2.95B 2.76B 5.16B 353B 5.27B 35.19B 13.62B 170B 13.84B 13.55B 592B | P/E Ratio 2026 * |
-
| P/E Ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 14B 2.07B 1.79B 1.65B 1.55B 2.89B 198B 2.95B 19.72B 7.63B 95.37B 7.76B 7.59B 332B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
37.5% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.69% | ||
| 1 week | -4.14% | ||
| Current month | -4.21% | ||
| 1 month | -8.21% | ||
| 3 months | -2.44% | ||
| 6 months | -5.52% | ||
| Current year | +0.27% |
| 1 week | 26.02 | 28.2 | |
| 1 month | 26.02 | 29.27 | |
| Current year | 24.12 | 29.6 | |
| 1 year | 24.12 | 29.6 | |
| 3 years | 23.85 | 45.18 | |
| 5 years | 14.37 | 45.18 | |
| 10 years | 14.37 | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 2019-12-19 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 2022-09-25 |
Zhigang Chang
IRC | Investor Relations Contact | 29 | 2024-07-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Long Xiang Cao
CHM | Chairman | 69 | 2014-03-09 |
Qu Rong Huang
BRD | Director/Board Member | 64 | 2014-03-09 |
Fei Cao
BRD | Director/Board Member | 43 | 2014-03-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-30 | Buy | Director | 30,000 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.69% | -4.14% | -5.21% | -10.76% | 3.59B | ||
| +0.82% | +4.01% | -11.30% | -3.81% | 13.31B | ||
| -1.10% | -2.21% | -35.37% | -56.82% | 4.92B | ||
| -0.22% | +2.94% | -9.20% | -2.82% | 4.74B | ||
| -1.86% | -5.35% | +8.38% | -21.79% | 3.78B | ||
| -1.61% | +0.40% | +2.70% | -43.28% | 3.76B | ||
| -0.91% | +1.00% | -13.63% | -5.90% | 3.13B | ||
| -1.50% | -2.43% | -13.60% | -32.08% | 2.25B | ||
| -6.14% | -3.41% | -15.13% | +24.40% | 1.72B | ||
| -0.89% | -1.28% | -18.88% | -16.03% | 1.68B | ||
| Average | -1.61% | -2.07% | -11.12% | -16.89% | 4.29B | |
| Weighted average by Cap. | -0.85% | -0.58% | -11.10% | -16.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.72B 254M 221M 204M 191M 356M 24.36B 364M 2.43B 940M 11.74B 955M 935M 40.83B | - |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 26.37 ¥ | -2.69% | 6,895,800 |
| 26-06-10 | 27.10 ¥ | -1.38% | 4,635,421 |
| 26-06-09 | 27.48 ¥ | -0.36% | 5,031,789 |
| 26-06-08 | 27.58 ¥ | -1.46% | 5,352,497 |
| 26-06-05 | 27.99 ¥ | +1.74% | 3,954,459 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600566 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















